| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 RUNX1 GTF2IRD1 ZNF181 IKZF5 HIVEP3 BMI1 ZNF430 ZNF34 ZBTB45 ZFHX4 ZNF792 ZNF41 ZNF667 KDM2B ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 TAF1 PRDM15 NR1D2 | 9.84e-07 | 1459 | 165 | 31 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF138 HIVEP1 HIVEP2 OVOL3 ZNF224 ZNF524 RUNX1 GTF2IRD1 ZNF181 IKZF5 HIVEP3 BMI1 ZNF430 ZNF34 ZBTB45 ZFHX4 ZNF792 ZNF41 ZNF667 KDM2B ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 NR1D2 | 3.72e-06 | 1244 | 165 | 27 | GO:0000978 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 RUNX1 GTF2IRD1 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB45 ZBTB46 CSRNP2 ZFHX4 CSRNP3 ZNF792 ZNF41 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 NR1D2 | 4.56e-06 | 1412 | 165 | 29 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF138 HIVEP1 HIVEP2 OVOL3 ZNF224 ZNF524 RUNX1 GTF2IRD1 ZNF181 IKZF5 HIVEP3 BMI1 ZNF430 ZNF34 ZBTB45 ZFHX4 ZNF792 ZNF41 ZNF667 KDM2B ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 NR1D2 | 5.53e-06 | 1271 | 165 | 27 | GO:0000987 |
| GeneOntologyMolecularFunction | protein serine kinase activity | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 TAF1 CDK11B MAP2K2 RPS6KL1 | 1.06e-05 | 363 | 165 | 13 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 TAF1 CDK11B MAP2K2 RPS6KL1 | 8.88e-05 | 446 | 165 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.07e-04 | 57 | 165 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.37e-04 | 60 | 165 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.01e-04 | 65 | 165 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.01e-04 | 65 | 165 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CTU2 GAK CAMK1D RPS6KA1 DAPK2 PAPOLB SIK3 POLR3A NUAK2 PARP4 MB21D2 NUAK1 COQ8A DSTYK PKN2 TAF1 CDK11B MAP2K2 RPS6KL1 | 2.83e-04 | 938 | 165 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.92e-04 | 75 | 165 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 4.13e-04 | 18 | 165 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.43e-04 | 77 | 165 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | protein kinase activity | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 COQ8A DSTYK PKN2 TAF1 CDK11B MAP2K2 RPS6KL1 | 4.73e-04 | 600 | 165 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 4.87e-04 | 19 | 165 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.26e-04 | 83 | 165 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 7.60e-04 | 22 | 165 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 7.70e-04 | 50 | 165 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.14e-03 | 193 | 165 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.28e-03 | 197 | 165 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.40e-03 | 27 | 165 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.45e-03 | 100 | 165 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.88e-03 | 334 | 165 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 COQ8A DSTYK PKN2 TAF1 CDK11B MAP2K2 RPS6KL1 | 2.31e-03 | 709 | 165 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | taste receptor activity | 2.52e-03 | 33 | 165 | 3 | GO:0008527 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 1.72e-05 | 7 | 165 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system process | 3.70e-05 | 24 | 165 | 4 | GO:0031645 | |
| GeneOntologyBiologicalProcess | lymphocyte anergy | 5.79e-05 | 10 | 165 | 3 | GO:0002249 | |
| GeneOntologyBiologicalProcess | regulation of T cell anergy | 5.79e-05 | 10 | 165 | 3 | GO:0002667 | |
| GeneOntologyBiologicalProcess | T cell anergy | 5.79e-05 | 10 | 165 | 3 | GO:0002870 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte anergy | 5.79e-05 | 10 | 165 | 3 | GO:0002911 | |
| GeneOntologyBiologicalProcess | negative regulation of myelination | 7.91e-05 | 11 | 165 | 3 | GO:0031642 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 8.47e-05 | 175 | 165 | 8 | GO:0031644 | |
| GeneOntologyBiologicalProcess | response to histamine | 1.05e-04 | 12 | 165 | 3 | GO:0034776 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.42e-04 | 16 | 163 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB1 GABRB2 GABRB3 SYNE1 ADGRB1 LRRTM1 CHRNE CHRNG SHISA9 LRP1 DNM3 | 3.48e-04 | 405 | 163 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 4.11e-04 | 19 | 163 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 5.58e-04 | 21 | 163 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRB1 GABRB2 GABRB3 ADGRB1 LRRTM1 CHRNE SHISA9 DST MTMR2 LRP1 DNM3 ARHGEF2 | 6.02e-04 | 503 | 163 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRB2 GABRB3 SYNE1 ADGRB1 LRRTM1 CHRNE CHRNG SHISA9 MTMR2 LRP1 DNM3 LPAR2 | 6.72e-04 | 583 | 163 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | myosin filament | 9.44e-04 | 25 | 163 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.02e-03 | 57 | 163 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.03e-03 | 201 | 163 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | myosin II complex | 1.32e-03 | 28 | 163 | 3 | GO:0016460 | |
| MousePheno | abnormal nervous system electrophysiology | GABRB1 GABRB3 CACNA1B HIVEP2 HCN3 SIK3 KCNK9 SHISA9 PER3 COQ8A FIG4 MTMR2 ZFHX2 | 5.88e-06 | 329 | 122 | 13 | MP:0002272 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 9.45e-15 | 694 | 164 | 32 | IPR013087 |
| Domain | - | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 3.43e-14 | 679 | 164 | 31 | 3.30.160.60 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 1.96e-13 | 775 | 164 | 32 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 2.11e-13 | 777 | 164 | 32 | PS00028 |
| Domain | Znf_C2H2-like | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 4.05e-13 | 796 | 164 | 32 | IPR015880 |
| Domain | Znf_C2H2 | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 5.48e-13 | 805 | 164 | 32 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF703 ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 OVOL3 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 6.05e-13 | 808 | 164 | 32 | SM00355 |
| Domain | zf-C2H2 | ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 ZNF224 ZNF524 ZNF181 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZFHX4 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 2.24e-12 | 693 | 164 | 29 | PF00096 |
| Domain | GABAAb_rcpt | 6.65e-07 | 3 | 164 | 3 | IPR002289 | |
| Domain | zf-C2H2_6 | ZNF133 ZNF555 ZNF224 ZNF524 ZNF181 ZBTB44 PRDM10 ZNF792 ZNF667 ZNF479 ZSCAN2 ZNF615 ZNF541 | 4.22e-06 | 314 | 164 | 13 | PF13912 |
| Domain | Neurotransmitter_ion_chnl_CS | 4.52e-05 | 45 | 164 | 5 | IPR018000 | |
| Domain | Neur_chan_memb | 5.03e-05 | 46 | 164 | 5 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 5.59e-05 | 47 | 164 | 5 | IPR006029 | |
| Domain | - | 5.59e-05 | 47 | 164 | 5 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 5.59e-05 | 47 | 164 | 5 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 5.59e-05 | 47 | 164 | 5 | PS00236 | |
| Domain | Neur_channel | 5.59e-05 | 47 | 164 | 5 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.59e-05 | 47 | 164 | 5 | IPR006202 | |
| Domain | ZF_CCHC_HIVEP | 7.66e-05 | 2 | 164 | 2 | PS51811 | |
| Domain | Ser/Thr_kinase_AS | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 7.68e-05 | 357 | 164 | 12 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 8.76e-05 | 362 | 164 | 12 | PS00108 |
| Domain | Kinase-like_dom | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 DST NUAK1 COQ8A DSTYK DNM3 PKN2 CDK11B MAP2K2 RPS6KL1 | 8.93e-05 | 542 | 164 | 15 | IPR011009 |
| Domain | Pkinase | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 1.42e-04 | 381 | 164 | 12 | PF00069 |
| Domain | CSRNP_N | 2.29e-04 | 3 | 164 | 2 | IPR031972 | |
| Domain | Cys/Ser-rich_nuc_prot | 2.29e-04 | 3 | 164 | 2 | IPR023260 | |
| Domain | CSRNP_N | 2.29e-04 | 3 | 164 | 2 | PF16019 | |
| Domain | Myosin_N | 2.80e-04 | 15 | 164 | 3 | PF02736 | |
| Domain | Myosin_N | 2.80e-04 | 15 | 164 | 3 | IPR004009 | |
| Domain | KRAB | ZNF133 ZNF555 ZNF224 ZNF181 ZNF430 ZNF34 ZNF792 ZNF41 ZNF667 ZNF479 ZNF615 | 3.32e-04 | 358 | 164 | 11 | PS50805 |
| Domain | KRAB | ZNF133 ZNF555 ZNF224 ZNF181 ZNF430 ZNF34 ZNF792 ZNF41 ZNF667 ZNF479 ZNF615 | 3.32e-04 | 358 | 164 | 11 | PF01352 |
| Domain | S_TKc | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 | 3.40e-04 | 359 | 164 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_DOM | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 COQ8A DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 4.23e-04 | 493 | 164 | 13 | PS50011 |
| Domain | KRAB | ZNF133 ZNF555 ZNF224 ZNF181 ZNF430 ZNF34 ZNF792 ZNF41 ZNF667 ZNF479 ZNF615 | 4.29e-04 | 369 | 164 | 11 | SM00349 |
| Domain | KRAB | ZNF133 ZNF555 ZNF224 ZNF181 ZNF430 ZNF34 ZNF792 ZNF41 ZNF667 ZNF479 ZNF615 | 4.38e-04 | 370 | 164 | 11 | IPR001909 |
| Domain | Myosin_tail_1 | 4.92e-04 | 18 | 164 | 3 | PF01576 | |
| Domain | Myosin_tail | 4.92e-04 | 18 | 164 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 5.81e-04 | 19 | 164 | 3 | IPR027401 | |
| Domain | - | 5.81e-04 | 19 | 164 | 3 | 4.10.270.10 | |
| Domain | Ribosomal_S10 | 7.53e-04 | 5 | 164 | 2 | IPR001848 | |
| Domain | PROTEIN_KINASE_ATP | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 7.58e-04 | 459 | 164 | 12 | PS00107 |
| Domain | GABAA/Glycine_rcpt | 1.03e-03 | 23 | 164 | 3 | IPR006028 | |
| Domain | Prot_kinase_dom | GAK CAMK1D RPS6KA1 DAPK2 SIK3 NUAK2 NUAK1 DSTYK PKN2 CDK11B MAP2K2 RPS6KL1 | 1.31e-03 | 489 | 164 | 12 | IPR000719 |
| Domain | HormR | 1.33e-03 | 25 | 164 | 3 | SM00008 | |
| Domain | TAS2R | 1.49e-03 | 26 | 164 | 3 | PF05296 | |
| Domain | T2R | 1.49e-03 | 26 | 164 | 3 | IPR007960 | |
| Domain | HRM | 1.85e-03 | 28 | 164 | 3 | PF02793 | |
| Domain | Znf_U1 | 2.05e-03 | 29 | 164 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 2.05e-03 | 29 | 164 | 3 | SM00451 | |
| Domain | Arm | 2.49e-03 | 31 | 164 | 3 | PF00514 | |
| Pubmed | ZNF133 ABCF1 PCGF2 HIVEP2 GTPBP6 IFT172 TNPO2 SYNE1 ZNF224 STAM RUNX1 PIAS2 ZNF181 ZNF34 ZBTB44 DST TTC7B MTMR2 LRP1 DNM3 FIBP TTC17 TAF1 NR1D2 ARMC8 | 3.30e-09 | 1285 | 168 | 25 | 35914814 | |
| Pubmed | 3.62e-08 | 8 | 168 | 4 | 26993635 | ||
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 1.11e-07 | 3 | 168 | 3 | 7893750 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 1282920 | ||
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 1.11e-07 | 3 | 168 | 3 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 1.11e-07 | 3 | 168 | 3 | 15337300 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 10388558 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 23300874 | ||
| Pubmed | ABCF1 RPS6KA1 UBE3B AMBRA1 SIK3 POLR3A FARP2 PARP4 DST COQ8A ARHGEF1 DSTYK TIMELESS ARHGEF2 RIC1 | 6.99e-07 | 650 | 168 | 15 | 38777146 | |
| Pubmed | ZNF142 HIVEP1 HIVEP2 SYNE1 SIK3 CBLB PIAS2 DST ARHGEF1 TAF1 PIBF1 MAP2K2 OBI1 | 7.85e-07 | 486 | 168 | 13 | 20936779 | |
| Pubmed | 1.10e-06 | 5 | 168 | 3 | 15198677 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP HIVEP2 GTPBP6 PCNX3 UBE3B AMBRA1 INO80 GTF2IRD1 TNFRSF21 HIVEP3 CELSR1 C2CD3 DST NUAK1 PPP1R15B ARHGEF2 HERC1 ABCC10 RIC1 | 1.86e-06 | 1105 | 168 | 19 | 35748872 |
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 2.19e-06 | 6 | 168 | 3 | 29706582 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 2.19e-06 | 6 | 168 | 3 | 10077619 | |
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 2.19e-06 | 6 | 168 | 3 | 10023064 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 GAK ABCF1 MYH13 RPS6KA1 SIK3 CBLB NUAK2 GTF2H4 DST NUAK1 DNM3 FIBP PKN2 CDK11B ARHGEF2 MAP2K2 | 2.24e-06 | 910 | 168 | 17 | 36736316 |
| Pubmed | 3.02e-06 | 181 | 168 | 8 | 37372979 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 3.82e-06 | 7 | 168 | 3 | 20843900 | |
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 35210422 | ||
| Pubmed | Quick validation of genetic quality for conditional alleles in mice. | 3.82e-06 | 7 | 168 | 3 | 33540482 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 HIVEP1 HIVEP2 TEX2 DAPK2 SIK3 DENND2B NUAK2 C2CD3 DST ARHGEF1 DSTYK ARHGEF2 PIBF1 MAP2K2 OBI1 | 4.83e-06 | 861 | 168 | 16 | 36931259 |
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 11528422 | ||
| Pubmed | HIVEP1 PIAS2 DST ZFHX4 BRCA2 FIZ1 LRP1 KDM2B ZFHX3 TAF1 OBI1 | 6.62e-06 | 418 | 168 | 11 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF703 HIVEP1 HIVEP2 TNPO2 INO80 PIAS2 ZFHX4 KDM2B ZFHX3 TAF1 | 8.85e-06 | 351 | 168 | 10 | 38297188 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ABCF1 PCGF2 GTPBP6 TNPO2 INO80 POLR3A BMI1 GTF2H4 TTC7B TTC17 TAF1 OBI1 | 1.21e-05 | 533 | 168 | 12 | 30554943 |
| Pubmed | PCGF2 CAMK1D RPS6KA1 DAPK2 SIK3 POLR3A BMI1 ZBTB45 MTMR2 LRP1 TAF1 CDK11B MAP2K2 PCSK4 | 1.37e-05 | 730 | 168 | 14 | 34857952 | |
| Pubmed | 1.49e-05 | 31 | 168 | 4 | 21985497 | ||
| Pubmed | Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma. | 2.32e-05 | 2 | 168 | 2 | 20717685 | |
| Pubmed | Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis. | 2.32e-05 | 2 | 168 | 2 | 17452456 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26950270 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23486367 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 12196556 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20404140 | ||
| Pubmed | Requirement of mammalian Timeless for circadian rhythmicity. | 2.32e-05 | 2 | 168 | 2 | 14564007 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.32e-05 | 2 | 168 | 2 | 9382868 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 11150240 | ||
| Pubmed | SUMOylation of GTF2IRD1 regulates protein partner interactions and ubiquitin-mediated degradation. | 2.32e-05 | 2 | 168 | 2 | 23145142 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 30054673 | ||
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 2.32e-05 | 2 | 168 | 2 | 10873665 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25241062 | ||
| Pubmed | BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer. | 2.32e-05 | 2 | 168 | 2 | 20170541 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16826520 | ||
| Pubmed | Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. | 2.32e-05 | 2 | 168 | 2 | 13679430 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14503638 | ||
| Pubmed | Direct binding of GABAA receptor β2 and β3 subunits to gephyrin. | 2.32e-05 | 2 | 168 | 2 | 23205938 | |
| Pubmed | A new serine/threonine protein kinase, Omphk1, essential to ventral body wall formation. | 2.32e-05 | 2 | 168 | 2 | 16715502 | |
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 2.32e-05 | 2 | 168 | 2 | 21735059 | |
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 2.32e-05 | 2 | 168 | 2 | 18650446 | |
| Pubmed | Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma. | 2.32e-05 | 2 | 168 | 2 | 21059209 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22989919 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 7688301 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17545584 | ||
| Pubmed | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties. | 2.32e-05 | 2 | 168 | 2 | 2247438 | |
| Pubmed | The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. | 2.32e-05 | 2 | 168 | 2 | 12626518 | |
| Pubmed | Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer. | 2.32e-05 | 2 | 168 | 2 | 21162745 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 23898191 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 2.32e-05 | 2 | 168 | 2 | 11744674 | |
| Pubmed | HIVEP1 STAM CBLB PIAS2 DENND2B ZBTB44 DST CSRNP2 ZNF41 PPP1R15B LRP1 HERC1 | 3.32e-05 | 591 | 168 | 12 | 15231748 | |
| Pubmed | 3.88e-05 | 14 | 168 | 3 | 22768092 | ||
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | GAK IFT172 TTI2 STAM CBLB COQ8A SLC34A1 ARHGEF1 ZFHX3 ARHGEF2 | 4.02e-05 | 419 | 168 | 10 | 33001583 |
| Pubmed | LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. | 4.83e-05 | 15 | 168 | 3 | 14976552 | |
| Pubmed | 5.92e-05 | 16 | 168 | 3 | 16494860 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 6.94e-05 | 3 | 168 | 2 | 26059207 | |
| Pubmed | Transgenic overexpression of furin increases epileptic susceptibility. | 6.94e-05 | 3 | 168 | 2 | 30333479 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 36515178 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31553907 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 17151361 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 22028665 | ||
| Pubmed | Protein kinase N2 mediates flow-induced endothelial NOS activation and vascular tone regulation. | 6.94e-05 | 3 | 168 | 2 | 34499618 | |
| Pubmed | N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. | 6.94e-05 | 3 | 168 | 2 | 23917429 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 20515922 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 9487388 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21540184 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 3782129 | ||
| Pubmed | A novel zinc finger coiled-coil domain in a family of nuclear proteins. | 6.94e-05 | 3 | 168 | 2 | 1412709 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 17145810 | ||
| Pubmed | ARNTL, CLOCK and PER3 polymorphisms - links with chronotype and affective dimensions. | 6.94e-05 | 3 | 168 | 2 | 28708003 | |
| Pubmed | Protrudin modulates seizure activity through GABAA receptor regulation. | 6.94e-05 | 3 | 168 | 2 | 31772151 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19409954 | ||
| Pubmed | The acetylcholine receptor gamma-to-epsilon switch occurs in individual endplates. | 6.94e-05 | 3 | 168 | 2 | 15883046 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 25742952 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 25332232 | ||
| Pubmed | Dampening of death pathways by schnurri-2 is essential for T-cell development. | 6.94e-05 | 3 | 168 | 2 | 21475200 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 18281286 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 1991318 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12012784 | ||
| Pubmed | Regulation of hematopoietic stem cells using protein transduction domain-fused Polycomb. | 6.94e-05 | 3 | 168 | 2 | 22634509 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12193603 | ||
| Pubmed | Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. | 6.94e-05 | 3 | 168 | 2 | 19927127 | |
| Pubmed | 7.16e-05 | 17 | 168 | 3 | 7557990 | ||
| Pubmed | 8.56e-05 | 18 | 168 | 3 | 19078961 | ||
| Pubmed | 8.56e-05 | 18 | 168 | 3 | 18985723 | ||
| Pubmed | 8.68e-05 | 92 | 168 | 5 | 20301317 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF133 HIVEP2 GTPBP6 GTF2IRD1 DENND2B FARP2 SHISA9 HIVEP3 ZBTB46 COQ8A LRP1 ZFHX2 ZFHX3 TTC17 MAP2K2 PRDM15 RPS6KL1 RIC1 STEAP1 | 1.14e-04 | 1489 | 168 | 19 | 28611215 |
| Pubmed | 1.19e-04 | 20 | 168 | 3 | 21689717 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.20e-04 | 157 | 168 | 6 | 30686591 | |
| Pubmed | TTI2 POLR2D POLR3A GTF2H4 ARHGEF1 TAF1 CDK11B ARHGEF2 MAP2K2 | 1.26e-04 | 390 | 168 | 9 | 17643375 | |
| Pubmed | 1.38e-04 | 21 | 168 | 3 | 25708312 | ||
| Pubmed | 1.38e-04 | 4 | 168 | 2 | 22474383 | ||
| Pubmed | Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond. | 1.38e-04 | 4 | 168 | 2 | 9153995 | |
| Cytoband | 8q24.3 | 6.31e-05 | 113 | 168 | 5 | 8q24.3 | |
| Cytoband | 9q33-q34 | 7.95e-05 | 4 | 168 | 2 | 9q33-q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | OVOL3 FPR3 ZNF224 ZNF524 ZNF181 ZBTB45 PLA2G4C ZNF792 ARHGEF1 FIZ1 ZNF667 ZNF615 IL4I1 ZNF541 | 1.36e-04 | 1192 | 168 | 14 | chr19q13 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF133 ZNF138 ZNF142 HIVEP1 HIVEP2 ZNF555 ZNF224 ZNF524 ZNF181 IKZF5 HIVEP3 ZNF430 ZNF34 ZBTB44 ZBTB45 ZBTB46 PRDM10 ZNF792 ZNF41 FIZ1 ZNF667 PRDM12 ZFHX2 ZNF479 ZFHX3 ZSCAN2 ZNF615 PRDM15 ZNF541 | 1.52e-14 | 718 | 128 | 29 | 28 |
| GeneFamily | Myosin heavy chains | 1.48e-04 | 15 | 128 | 3 | 1098 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.48e-04 | 15 | 128 | 3 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.19e-04 | 17 | 128 | 3 | 1197 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.09e-04 | 19 | 128 | 3 | 563 | |
| GeneFamily | Ring finger proteins|Polycomb group ring fingers | 1.02e-03 | 7 | 128 | 2 | 61 | |
| GeneFamily | Taste 2 receptors | 2.63e-03 | 39 | 128 | 3 | 1162 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 HIVEP2 MOSPD2 AVPR1A TEX2 CBLB DENND2B IKZF5 BMI1 EDEM3 ZBTB44 PARP4 ZBTB46 DST DSTYK MTMR2 PHLPP1 ARMC8 | 9.35e-06 | 854 | 167 | 18 | M1533 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | ZNF133 TNPO2 ZNF524 GTF2H4 GLP1R TTC17 LPAR2 ARHGEF2 MAP2K2 RNF207 ABCC10 | 1.18e-05 | 338 | 167 | 11 | M17094 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 HIVEP2 MOSPD2 AVPR1A TEX2 CBLB DENND2B IKZF5 BMI1 EDEM3 ZBTB44 PARP4 ZBTB46 DST DSTYK MTMR2 PHLPP1 ARMC8 | 1.58e-05 | 888 | 167 | 18 | MM1018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 HIVEP2 STAM SIK3 RUNX1 CBLB DENND2B C2CD3 DST NUAK1 BRCA2 PHLPP1 PDS5A ZFHX3 PKN2 KAZN PIBF1 | 3.55e-05 | 856 | 167 | 17 | M4500 |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 4.33e-05 | 199 | 167 | 8 | M5268 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 4.49e-05 | 200 | 167 | 8 | M7256 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP | 4.49e-05 | 200 | 167 | 8 | M3925 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 HIVEP2 STAM RUNX1 CBLB C2CD3 DST NUAK1 PHLPP1 PDS5A PKN2 PIBF1 | 4.73e-05 | 466 | 167 | 12 | M13522 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | PABIR1 ZNF142 PCGF2 MOSPD2 PCNX3 TRMT112 TTI2 RUNX1 GTF2IRD1 PIAS2 POLR3A HIVEP3 MTMR2 TIMELESS PLD2 NR1D2 | 5.13e-05 | 794 | 167 | 16 | MM982 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.52e-07 | 190 | 168 | 8 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 6.71e-06 | 185 | 168 | 7 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-05 | 199 | 168 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.09e-05 | 77 | 168 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.11e-05 | 200 | 168 | 7 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; PC3; HT_HG-U133A | 1.61e-05 | 199 | 166 | 9 | 4490_DN | |
| Drug | Adinazolam | 2.08e-05 | 8 | 166 | 3 | DB00546 | |
| Drug | Fludiazepam | 2.08e-05 | 8 | 166 | 3 | DB01567 | |
| Drug | Clotiazepam | 2.08e-05 | 8 | 166 | 3 | DB01559 | |
| Drug | Cinolazepam | 2.08e-05 | 8 | 166 | 3 | DB01594 | |
| Drug | Prazepam | 2.08e-05 | 8 | 166 | 3 | DB01588 | |
| Drug | Estazolam | 2.08e-05 | 8 | 166 | 3 | DB01215 | |
| Drug | Halazepam | 2.08e-05 | 8 | 166 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 2.08e-05 | 8 | 166 | 3 | ctd:C091518 | |
| Drug | Ethchlorvynol | 3.10e-05 | 9 | 166 | 3 | DB00189 | |
| Drug | Diazepam | 3.10e-05 | 9 | 166 | 3 | DB00829 | |
| Drug | Chlordiazepoxide | 4.40e-05 | 10 | 166 | 3 | DB00475 | |
| Drug | Clobazam | 4.40e-05 | 10 | 166 | 3 | DB00349 | |
| Drug | Bromazepam | 4.40e-05 | 10 | 166 | 3 | DB01558 | |
| Drug | Oxazepam | 4.40e-05 | 10 | 166 | 3 | DB00842 | |
| Drug | Midazolam | 4.40e-05 | 10 | 166 | 3 | DB00683 | |
| Drug | Flurazepam | 4.40e-05 | 10 | 166 | 3 | DB00690 | |
| Drug | Clonazepam | 4.40e-05 | 10 | 166 | 3 | DB01068 | |
| Drug | phaclofen | 5.28e-05 | 2 | 166 | 2 | ctd:C052329 | |
| Drug | Alprazolam | 6.02e-05 | 11 | 166 | 3 | DB00404 | |
| Drug | Temazepam | 6.02e-05 | 11 | 166 | 3 | DB00231 | |
| Drug | Nitrazepam | 6.02e-05 | 11 | 166 | 3 | DB01595 | |
| Drug | Lorazepam | 6.02e-05 | 11 | 166 | 3 | DB00186 | |
| Drug | Triazolam | 6.02e-05 | 11 | 166 | 3 | DB00897 | |
| Drug | Clorazepate | 6.02e-05 | 11 | 166 | 3 | DB00628 | |
| Drug | Etomidate | 6.02e-05 | 11 | 166 | 3 | ctd:D005045 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.69e-05 | 10 | 156 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.08e-05 | 12 | 156 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.08e-05 | 12 | 156 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.99e-05 | 13 | 156 | 3 | DOID:0050787 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.99e-05 | 13 | 156 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 6.29e-05 | 15 | 156 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.22e-04 | 48 | 156 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.32e-04 | 49 | 156 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | advanced sleep phase syndrome (is_implicated_in) | 1.65e-04 | 4 | 156 | 2 | DOID:0050628 (is_implicated_in) | |
| Disease | Globozoospermia | 1.65e-04 | 4 | 156 | 2 | C0403825 | |
| Disease | Bipolar Disorder | GABRB1 GABRB2 GABRB3 CACNA1B WFS1 SYNE1 PER3 BRCA2 TIMELESS NOS3 | 2.38e-04 | 477 | 156 | 10 | C0005586 |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.39e-04 | 57 | 156 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | contactin-2 measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0008100 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.55e-04 | 71 | 156 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Akinetic Petit Mal | 5.73e-04 | 7 | 156 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 5.73e-04 | 7 | 156 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 5.73e-04 | 7 | 156 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 5.73e-04 | 7 | 156 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 5.73e-04 | 7 | 156 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 5.73e-04 | 7 | 156 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 5.73e-04 | 7 | 156 | 2 | C0014553 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 5.73e-04 | 7 | 156 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Global developmental delay | 7.23e-04 | 133 | 156 | 5 | C0557874 | |
| Disease | osteoarthritis, spine, body mass index | 7.62e-04 | 8 | 156 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | cleft lip | 8.17e-04 | 284 | 156 | 7 | EFO_0003959 | |
| Disease | Malignant tumor of prostate | 9.76e-04 | 9 | 156 | 2 | cv:C0376358 | |
| Disease | mean arterial pressure | 1.40e-03 | 499 | 156 | 9 | EFO_0006340 | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.08e-03 | 13 | 156 | 2 | cv:C4082197 | |
| Disease | Saldino-Noonan Syndrome | 2.42e-03 | 14 | 156 | 2 | C0036069 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 2.42e-03 | 14 | 156 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | red blood cell density measurement | HIVEP1 INO80 SIK3 RUNX1 DENND2B FARP2 ZBTB46 DST SLC34A1 DNM3 PKN2 PIBF1 | 2.57e-03 | 880 | 156 | 12 | EFO_0007978 |
| Disease | Intellectual Disability | 2.69e-03 | 447 | 156 | 8 | C3714756 | |
| Disease | non-alcoholic fatty liver disease | 2.88e-03 | 182 | 156 | 5 | EFO_0003095 | |
| Disease | Antihypertensive use measurement | 2.94e-03 | 265 | 156 | 6 | EFO_0009927 | |
| Disease | pulse pressure measurement | TEX2 TTI2 INO80 SLC39A10 OMD HIVEP3 ZBTB46 ZFHX4 LRP1 ZFHX3 PKN2 CDK11B MAP2K2 RNF207 OBI1 ABCC10 | 2.95e-03 | 1392 | 156 | 16 | EFO_0005763 |
| Disease | mean platelet volume | LRRC66 NIBAN1 HIVEP2 PCNX3 TEX2 SIK3 RUNX1 TNFRSF21 DENND2B CHRNE DSTYK DNM3 NOS3 | 3.08e-03 | 1020 | 156 | 13 | EFO_0004584 |
| Disease | decreased susceptibility to hepatitis C infection | 3.17e-03 | 16 | 156 | 2 | EFO_0010101 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.17e-03 | 16 | 156 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Polydactyly | 3.51e-03 | 117 | 156 | 4 | C0152427 | |
| Disease | longevity | 4.12e-03 | 284 | 156 | 6 | EFO_0004300 | |
| Disease | disease progression measurement | 4.17e-03 | 61 | 156 | 3 | EFO_0008336 | |
| Disease | arterial stiffness measurement | 4.77e-03 | 64 | 156 | 3 | EFO_0004517 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MIRRVKRFLSAHEHP | 391 | Q8N1M1 | |
| TPTHGEMRKNHRLKI | 676 | Q8NE71 | |
| QVKRRPAHLMALLQH | 51 | Q92888 | |
| ASLHRTLKEILRNPM | 191 | Q96AK3 | |
| SIHIDQMPQTRLIHL | 1366 | O14514 | |
| NPIRVRTHYLHTIMK | 261 | Q9H175 | |
| LRSPHTHSMARGVRK | 331 | P07510 | |
| TELHHVRTLKIMTRL | 246 | Q92974 | |
| LPRTAHRLLIFKHMV | 1141 | Q8IYW2 | |
| RHVEKSMNLHLLARS | 26 | Q9NZW4 | |
| TLMIQLLRGVKHLHD | 541 | P21127 | |
| SLVRMLRSNLHSIHK | 2491 | Q9NYQ6 | |
| ASRRILLHPSTEHMV | 961 | Q9C0C7 | |
| LPRLPKRHSHDDMLL | 566 | P78524 | |
| TTRHLRPDMKTHLDR | 801 | Q00975 | |
| HAMSPRLRHVLLELL | 336 | Q04844 | |
| HRPSGLIMARKLIHL | 91 | P36507 | |
| MLRSHVRELLDLHKQ | 511 | Q29RF7 | |
| HNPDRRTKMVSIHSL | 41 | Q6ZRI8 | |
| DHRKPHSFLSQRIML | 756 | Q4ADV7 | |
| NLSREELHNMLRLHK | 151 | Q9ULG1 | |
| PGLHSFTDHQRLMKR | 356 | Q9NPC2 | |
| AMHLRRKELHQLLPH | 486 | Q9NRJ5 | |
| RSHLMPRLKESRSHE | 121 | Q5VWQ8 | |
| HRRLLHRVLMAPVTF | 1001 | Q5T3U5 | |
| PSGKHILRRHLAEEM | 661 | Q674X7 | |
| KLHDRNQPVTLDMRH | 126 | Q8IYB1 | |
| RHRSVMAVQLHSRLP | 126 | Q9HBW0 | |
| VHPLMHLAAKLANRR | 91 | Q5H8A3 | |
| MPLHRSNLKRDVAHL | 226 | O43824 | |
| LFHGLRKLTTLHMRA | 156 | Q86UE6 | |
| RLEHLHIQRDSSMKP | 421 | P43220 | |
| SPRLSALLSHDKLMH | 2221 | Q03001 | |
| TLLISTLHRPMDLHV | 3266 | Q07954 | |
| LLLDVHIHKPMLNAR | 331 | Q9BZQ6 | |
| AKIHRNHMIKSSRPL | 226 | P25089 | |
| SHRKRGPMHSQLESL | 1541 | Q15751 | |
| MHRTTRIKITELNPH | 1 | P35226 | |
| PVLMRKHRRHDLPLE | 636 | Q13191 | |
| PIRVRTHFLHTIMKL | 261 | Q8WYN3 | |
| RHIADRMGTPHLQKV | 266 | Q9UQ16 | |
| LHPEDRSLMVAIHQK | 311 | P56645 | |
| HRVVAPGVRMALKLH | 1636 | Q9H6A9 | |
| RDMQHLVVRASKPAH | 396 | Q6UW60 | |
| KGAVHPAMANHLRLR | 371 | A0A0J9YX94 | |
| KIILIHIDSRLHTPM | 36 | P0C7T2 | |
| EPMLSHTVRKHLRKT | 76 | Q5W0B1 | |
| LDIHNIHVMRESLRK | 351 | Q13614 | |
| VHGVTVKNRMIRLHP | 131 | P18505 | |
| HGVTVKNRMIRLHPD | 131 | P47870 | |
| VHGVTVKNRMIRLHP | 131 | P28472 | |
| KLMTNLRSTHPHFVR | 661 | P12882 | |
| PDKLRLHMLRHSDRK | 656 | Q9NQV6 | |
| SNLRSHMRIHTLDKP | 256 | Q9H4Q4 | |
| SPVRMHSSRLHQIKQ | 76 | Q96E09 | |
| GHLEHMLLKPVNRIS | 276 | Q9UKK3 | |
| MSFHKLPADTRQRIH | 371 | Q9P1Z3 | |
| SNLSHHRRRKHKMVP | 151 | Q9H5V7 | |
| MRSLPKHERLVDLHG | 701 | Q6XUX3 | |
| RETRLPPIHLHRMKS | 301 | Q68CR7 | |
| MHLKHLRTLLSPQDG | 1 | Q9UG01 | |
| LLPGLIHVHRRKMFQ | 746 | P29474 | |
| RWMHSLKPLDHLITR | 581 | Q06495 | |
| MHRTTRIKITELNPH | 1 | P35227 | |
| QRMLTRHLKCHSPVR | 106 | O00110 | |
| DLKRHMRTHTGIRPF | 136 | O00110 | |
| RDKIMSSRKHLHLVD | 371 | Q9UP65 | |
| HMHRQKPPIIHRDLK | 161 | O14976 | |
| ILRHMPTLHRERQGL | 226 | Q8N878 | |
| RNLLSTRPHIDKIMS | 536 | Q8IUR7 | |
| SHVHLRKPAARSVVM | 401 | Q93033 | |
| RLIIRHMPLLSKLHL | 1231 | Q8NHM5 | |
| GRMLHESLRHAVPIT | 2031 | Q4AC94 | |
| KDRRLFMHHVSLEPI | 2316 | P51587 | |
| NHLTRSLMKKVHLRP | 326 | Q9UIK4 | |
| KIRTAHRRVMILNHP | 111 | Q9Y5T4 | |
| LHHKNTMRLLPTRRS | 616 | Q92562 | |
| LSPHLLKRHHARMQL | 56 | Q9BVV2 | |
| LHMRVEHTQLLHRVK | 166 | P0CW27 | |
| KIHNLIPVMLRHRLV | 586 | Q8NI60 | |
| TLSNLSRHLKLHRGM | 481 | Q96SL8 | |
| PRSCMLHRTELHVNI | 5391 | Q8NDH2 | |
| LMAILEHSHRIRFKL | 186 | Q9UHL9 | |
| LPRMQEKHLHLRVKL | 36 | O94887 | |
| LHRQHRGMTELEPSK | 36 | Q9ULF5 | |
| LLQTLRTHLILHMAR | 241 | Q2VPK5 | |
| SGRKHDLLMRALHLL | 31 | O75928 | |
| LPKLHTLRMSHNKLQ | 256 | Q99983 | |
| RMPSSHRILHKLCQG | 116 | Q96RQ9 | |
| LRTQVHQSMVPLLLH | 1161 | Q6ZUA9 | |
| TLIRALRTLIMKNHP | 531 | Q14995 | |
| RTFHMLERLLHAPPK | 61 | O43427 | |
| ASLLSNMSRHPLLHR | 616 | Q13835 | |
| PRNKVMEHRLRCHTV | 431 | Q8NHP6 | |
| LEQLRRTAMRVSPHH | 201 | Q01196 | |
| QMRIHKRLIDLHSPS | 81 | P60866 | |
| LILSLKRHTLHMGSN | 231 | P59534 | |
| LILSLKRHTLHMGSN | 216 | P59535 | |
| LMERLQGIVTRPHHL | 316 | Q6ZRF8 | |
| HQRTLMPEKLSHKLL | 196 | Q9Y2R9 | |
| LLDSRMSHSRLQHPL | 21 | Q9C004 | |
| TLLNSEVHMLLEHRK | 31 | O15514 | |
| HRHILKLLPSMEATG | 306 | O75509 | |
| HRQHLLSEMESLKPK | 5671 | Q8NF91 | |
| MHELLTSLVHKRLQV | 401 | Q8NDG6 | |
| HKSIHRRRTDPMVTL | 1371 | P21675 | |
| SRHMRRKHPEVLAVR | 1241 | P57071 | |
| PSLHKLSIMAHLARV | 466 | O14802 | |
| LSIMAHLARVKPHRT | 471 | O14802 | |
| EHLIRHMLVLDPNKR | 291 | Q9Y2K2 | |
| HKRHKTLRLGALPSM | 386 | Q9Y2K2 | |
| EKAHRPQREHMSRAL | 176 | B4DS77 | |
| MRKPDLALNHAHRSI | 241 | Q9BXB7 | |
| KLMTNLRSTHPHFVR | 661 | Q9Y623 | |
| RREIEIMSSLNHPHI | 101 | O60285 | |
| HIRREIEIMSSLNHP | 96 | Q9H093 | |
| VISPLELRMEELRHH | 211 | Q16513 | |
| STEGLPEIHHLRMKR | 286 | Q5SWA1 | |
| PEIHHLRMKRLEFLQ | 291 | Q5SWA1 | |
| HRMGIVHRDLKPENL | 136 | Q8IU85 | |
| THKLLRAAGHLVRAM | 711 | Q9UL12 | |
| SMLKRPVLLHLHQTA | 36 | Q9UHE8 | |
| LRKHNLELTMSPHCV | 86 | Q86WS4 | |
| HFLRTRAHPVMLKQT | 366 | Q92759 | |
| QRTTLILHMRIHDGK | 211 | Q5HYK9 | |
| RISPLMLHQRIHTSE | 341 | Q5HYK9 | |
| FPAKIRLMGHQRTHT | 521 | Q8N8J6 | |
| VPRTRKQIIHHLVQM | 856 | Q9UNS1 | |
| MRNAKEHVRLLPHSV | 3431 | Q86UP3 | |
| NRLPIRVLKMLSAHT | 46 | Q9H7S9 | |
| PISLRKHMRTHTREK | 436 | Q8NEP9 | |
| SNLATHRRTHMVEKP | 431 | Q7Z7L9 | |
| KSSLNVHMRTHRPER | 471 | Q96K62 | |
| MLSRLTQHKKIHTRE | 121 | P52744 | |
| KLLHTLEGHAMPIRS | 181 | Q9GZS3 | |
| NMLILKTHEEHVHRR | 1491 | Q9C0A1 | |
| EHLDRLMNLPLHSVK | 391 | Q9BZQ8 | |
| EVLRLILTHMEPEHR | 341 | Q6NXR4 | |
| RHMTIHVPLDASRSK | 391 | Q6T4P5 | |
| MKLLTHNLLSSHVRG | 1 | Q9UI30 | |
| LEVRIDRLIPHMHSI | 241 | O14787 | |
| LRRKHEILEASHMIQ | 281 | Q8WXW3 | |
| KHHMRVSRHIIRKPR | 471 | Q8NCP5 | |
| PSMLKKHIRTHTDVR | 1766 | Q5T1R4 | |
| HRHRMVVLEPLNKLL | 366 | Q9Y5S1 | |
| KLMTNLRSTHPHFVR | 661 | Q9UKX3 | |
| CLRSIMRRVNHKDPH | 46 | Q92783 | |
| RCHMVSRERLTIIPH | 181 | Q9Y6S9 | |
| KHPHDLVILMRQEAT | 61 | Q96AE7 | |
| LHRTPRKTSRMHLFI | 76 | P37288 | |
| SNLMRHRRIHTGEKP | 366 | Q96JC4 | |
| LIRHQRTHSGEKPMV | 481 | P52736 | |
| MLLHLTQHKRIHIRE | 216 | Q9H8G1 | |
| HVIPHKNRVLLFRTM | 646 | Q7Z3V4 | |
| SALRMHQRIHTGEKP | 466 | P51814 | |
| PTHVKSMQRLALILH | 761 | Q86TV6 | |
| TLIRHQKIHIRERSM | 576 | Q3KQV3 | |
| QALRKMPHIKHVDLR | 801 | O60346 | |
| MPHIKHVDLRLNVIR | 806 | O60346 | |
| AHKRVLIRHMLLHTG | 411 | P52746 | |
| NTLRRHAKRKHPEAM | 211 | Q96C55 | |
| SRLNRHSMVHTAEKP | 301 | Q9NZL3 | |
| HPARHRHLMKTLVKS | 206 | Q8IWB9 | |
| PSMLKKHIRTHTDVR | 1811 | P31629 | |
| ELVTRIHKVRQMHLL | 101 | Q92575 | |
| HRDLLRHKVLMSLLP | 111 | O14939 | |
| SMLKKHIRTHTDVRP | 2101 | P15822 | |
| CILKRHMRSHTGERP | 431 | Q86UZ6 | |
| ESLNMHLRNHIRLKP | 446 | Q2M3W8 | |
| ASLLIHSLRRHIQKM | 196 | Q9NYW5 | |
| FTRRPNLMKHQRIHT | 316 | Q8IZ26 | |
| AHMKRHRLQDHVEPI | 1306 | Q9H0D2 | |
| LEIHMRSVLHQTKAR | 1611 | Q15911 | |
| MAQLSPTRRHVKIEH | 851 | O76024 | |
| LVSKMLHVDPHQRLT | 651 | Q15418 | |
| SDRPAHKVSMLLLCH | 6 | Q8NI32 |